This is Jennifer who took Corona's first vaccine
18 March 2020, 14:25 BDT
worldwide spread of the pandemic epidemic created by the prevention of coronavirus. The first dose of this was applied to the body of a US woman. The experimental dose was then applied to two other women.
The woman's name is Jennifer Haller. The first coroner antidote was applied to Jennifer's body yesterday.
3-year-old Jennifer Haller has two children. He works as a startup's operations manager.
The experimental application of the malaria virus vaccine has begun from Monday. Jennifer Haller is the first in the world to have the Coronavirus vaccine applied.
Members of a community working on technology in Seattle were first elected to receive the coronavirus vaccine experimentally. The first volunteer to receive the vaccine was Jennifer Haller. He has experience working with the late Microsoft Vice President Paul Allen at the StratoLunch Space Venture. He is currently working at home-based Seattle-based startup company Autanley, which is working on machine learning.
Jennifer Haller received the first injection from Washington Research Institute at Kaiser Permanente in Seattle. Then you are in your own home. "After receiving the vaccine, I am very good. I didn't have any pains in my hands. It is much better than other flu vaccines. '
Autonomous CEO Scott Ferris has supported Jennifer Haller's participation in the experimental implementation of the Coronavirus vaccine. He said, "I am proud of his vaccine. Haller's job as Operations Manager is to maintain team morale. With the outbreak of coronavirus, keeping everyone's morale at work is becoming more of a challenge. We will now be hosting Virtual Happy Hour. '
The second volunteer on the Corona-vaccine-taking list is Neil Browning, a Microsoft network worker. He took one more dose. A total of three took the antidote on Monday.
The vaccine is named mordanus 'mRNA-122'. The vaccine uses the inactive fragment of messenger RNA from the SARS-COV-2 coronavirus. The goal of the first phase of this test is to test whether it is safe for the human body. Researchers claim that there is no risk of autoimmune transmission by the virus. Over the next one and a half years, a team led by Kaiser Permanente researcher Lisa Jackson will examine how effective the vaccine is against coronavirus.
According to a Live Science report, the experimental vaccine must undergo three phases in order to make the vaccine safe and useful worldwide. If you pass well in the first step, it can be useful for normal use in one to one and a half years. At the end of the first phase, the second phase will be tested on most people for a long time. In the third phase, the vaccine will be tested for 1 to 3 thousand people for a year or more. Thus, if the coronavirus vaccine is proven to be effective at all stages, it may be declared useful for human consumption. References: The New York Post, Al Jazeera and the BBC
No comments:
Post a Comment